Presentation
13 March 2024 A novel acquired resistance mechanism to to ALA-PDT with ABCG2 inhibition
Sharayu Chandratre, Bin Chen
Author Affiliations +
Abstract
The efficacy of ALA PDT in targeting tumour cells depends on the extent of PpIX accumulation at the target site. Targeting PpIX bioconversion enzyme FeCH and efflux transporter ABCG2 helps overcome intrinsic resistance to the therapy. However, the factors contributing to the development of acquired resistance to PDT are lesser known. Here we show that repeated exposure to ALA PDT results in the downregulation of PpIX biosynthetic machinery to a greater extent compared to the PpIX bioconversion by FeCH or its efflux by ABCG2. Overall, this study highlights the mechanisms involved in the development of acquired resistance to ALA PDT in tumour cell lines.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Sharayu Chandratre and Bin Chen "A novel acquired resistance mechanism to to ALA-PDT with ABCG2 inhibition", Proc. SPIE PC12823, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXXII, PC1282304 (13 March 2024); https://doi.org/10.1117/12.2692654
Advertisement
Advertisement
KEYWORDS
Resistance

Photodynamic therapy

Cancer

Fluorescence

Biomedical applications

Cell death

Fluorescence imaging

Back to Top